Here's the new version - without all the editing notes.
I'm going to check on modly vetting on two things before submission - so there's no need to point those out to me (unless you're a mod and feel like chiming in with a ruling ahead of schedule) ...
1. Does my referencing of ULC pass legal muster and not fall victim to "house of cards" ? I think it might work as is (after all, if ULC is ever repealed, then
no articles/journals would be archived, and I think I've allowed for that eventuality within the text) - but I'll want to double check that.
2. It does "duplicate" the Universal Clinical Trials Act, to some extent, but I wanted to establish those same requirements for funding within
this proposal, in the event that UCTA is ever repealed.
However, as a question: since UCTA allows for exceptions via appeal to the CEC, would it be possible to make that last clause (re: the control groups) a strong encouragement versus a requirement? I'd hate to
contradict UCTA (and I'd prefer to allow for situations where having a control group may not be the best option for a given research study) - but I'm uncertain.
Thoughts? (specific text, of course, follows ... )
Council: General Assembly
Category: Education and Creativity
Area of Effect: Education
UNDERSTANDING that safety and efficacy are important standards with regards to drug therapy;
ACKNOWLEDGING that a single drug may cause different benefits and/or side effects in each of the many species that are native to WA member nations;
DESIRING to more fully understand the potential benefits and harms with regards to using drugs among different species;
CREATES the International Drug Education Agency (IDEA) as a sub-committee of the World Assembly Food and Drug Regulatory Agency (WAFADRA);
SPECIFIES that IDEA employees will collect all data related to drug therapy conducted within NS nations;
1. This research will include data collected with regards to medication therapy and recreational drug use to allow for a better understanding of the risks and benefits all sorts of drugs;
2. Publishers of said research will receive appropriate monetary reimbursement, as determined by IDEA, in exchange for allowing wider access to this research;
3. Said research data will be made available to, at minimum, all medical professionals within WA nations; individual nations may provide this information to others within their own borders as they deem appropriate;
4. Non-WA nations may apply for access to this information; depending on the relative strength/weakness of the aforementioned nation's economy, a nominal fee may charged by the IDEA for access, as determined on a case-by-case basis;
ESTABLISHES the Database Of Clinical Treatments Under Study (DOCTUS) as a drug information and education library within the framework of the Universal Library Coalition (ULC);
1. IDEA will archive all research data within DOCTUS, including research data from studies and trials that have not been published, for whatever reason;
2. All research data within DOCTUS will be accompanied by a link to the relevant journal article, if the research has been published;
(a) IDEA will endeavor to offer appropriate monetary reimbursement to journals that are not currently archived in the ULC so that their research can be accessed through DOCTUS by credentialed individuals.
(b) If a journal and/or individual article is not available through DOCTUS or the ULC, appropriate citations will be listed so that the information in question can be accessed through alternate avenues.
DETAILS that IDEA medical professionals will review all published research on medication therapy and issue quarterly IDEA newsletters;
1. The newsletters will be written by health care professionals and will detail the most significant discoveries in drug therapy, such as new indications for an already discovered drug, new concerns regarding side effects for an established drug, new recommendations for use in certain populations, etc.;
2. IDEA professionals may include non-binding recommendations regarding suggested changes to currently established medication therapy standards;
3. The IDEA Quarterly will be provided to all interested nations free of charge and will be archived within DOCTUS with the appropriate reference citations;
RECOMMENDS that Health Research & Development Division of the WHA accept applications for funding from WA member nations for further research regarding already discovered medication therapies to better understand their safety and efficacy with long-term use;
1. Applications for funding must include details of how the study would be conducted and what drug(s) would be studied;
2. Funded studies must employ informed consent of all participants in the study;
3. Studies must have a control group;